VERSANT HCV Genotype 2.0 Assay (LiPA)
The VERSANT® HCV Genotype 2.0 Assay (LiPA)* utilizes the trusted reverse-hybridization technology to detect genotypes 1-6 and subtypes 1a and 1b. This assay is used with the Auto-LiPA 48 and AutoBlot 3000H automated systems to provide highly accurate identification of HCV genotypes and subtypes for optimal patient therapy.
*FDA - approved
VERSANT is a registered trademark of Siemens. All other marks are the property of their respective owners.